Company CVAbout Brooks Laboratories Ltd 
Brooks Laboratories Ltd
Micro Cap
Pharmaceuticals & Drugs
Brooks Laboratories Limited was incorporated on January 23, 2002. The company was initially promoted for manufacturing latest molecules in Injectables, tablets and dry syrups for the domestic customers. Brooks Laboratories is a pharmaceutical manufacturing company working on contract basis. The company has manufacturing plants at Baddi, Himachal Pradesh and Vadodara, Gujarat. Both the units are cGMP compliant in conformity with national and international standards.
Company Coordinates
Company Details
Village Kishanpura, Nilagarh Road Baddi Solan Himachal Pradesh : 174101
Registrar Details
Link Intime India Pvt Ltd, C-13 Pannalal Silk Compound, L B S Marg, Bhandup , Mumbai
Capital StructureCapital Structure
Present Equity Capital
INR 26.25 Cr
Number of Shares
2.62 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
28-Jul-2023
2.62
26.25
1543926
10
Right Issues
11-Feb-2020
2.47
24.70
7666390
10
Right Issues
11-Feb-2020
2.47
24.70
7666390
10
Right Issues
26-Jul-2019
1.7
17.04
212500
10
Conversion of Warrants
26-Jul-2019
1.7
17.04
212500
10
Conversion of Warrants
09-Jul-2019
1.68
16.82
637500
10
Conversion of Warrants
09-Jul-2019
1.68
16.82
637500
10
Conversion of Warrants
05-Sep-2011
1.62
16.19
6300000
10
Public Issues
05-Sep-2011
1.62
16.19
6300000
10
Public Issues
01-Nov-2010
98.36
9.84
5152412
10
Bonus
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 1 Schemes (9.9%)
FIIs
Held by 1 FIIs (0.0%)
Promoter with highest holding
Atul Ranchal (19.24%)
Highest Public shareholder
Quant Mutual Fund - Quant Business Cycle Fund (0%)
Individual Investors Holdings
32.13%
Board of Directors
Management
Designation
Remuneration
Rajnish Kumar Bedi
Independent Director
1.2 lacs
Deepak Mahajan
Independent Director
1.1 lacs
Sonia Gupta
Independent Director
1.1 lacs
Kaushalya Singh
Whole Time Director
1.73 lacs
Jitendra Pratap Singh
Whole Time Director
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
No Data Available for Raw Material Segmentation
No Data Available
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Drugs
55.03
100.00%
Drugs
Stock DNARevenue and Profits:
Net Sales:
38 Cr
(Quarterly Results - Dec 2024)
Net Profit:
-5 Cr
Pharmaceuticals & Drugs
INR 373 Cr (Micro Cap)
NA (Loss Making)
33
0.00%
0.14
-33.54%
6.21
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
